nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—SLC6A4—chronic obstructive pulmonary disease	0.384	1	CbGaD
Escitalopram—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0832	0.227	CbGbCtD
Escitalopram—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0413	0.112	CbGbCtD
Escitalopram—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0413	0.112	CbGbCtD
Escitalopram—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0314	0.0854	CbGbCtD
Escitalopram—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0314	0.0854	CbGbCtD
Escitalopram—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.028	0.0762	CbGbCtD
Escitalopram—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0263	0.0717	CbGbCtD
Escitalopram—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0178	0.0484	CbGbCtD
Escitalopram—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0173	0.0472	CbGbCtD
Escitalopram—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.017	0.0462	CbGbCtD
Escitalopram—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0151	0.0412	CbGbCtD
Escitalopram—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00887	0.0242	CbGbCtD
Escitalopram—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00838	0.0228	CbGbCtD
Escitalopram—Citalopram—SLC6A4—chronic obstructive pulmonary disease	0.00232	0.523	CrCbGaD
Escitalopram—Citalopram—CYP1A2—chronic obstructive pulmonary disease	0.00211	0.477	CrCbGaD
Escitalopram—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.0004	CcSEcCtD
Escitalopram—Pruritus—Aminophylline—chronic obstructive pulmonary disease	8.34e-05	0.000399	CcSEcCtD
Escitalopram—Shock—Salbutamol—chronic obstructive pulmonary disease	8.34e-05	0.000398	CcSEcCtD
Escitalopram—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.000398	CcSEcCtD
Escitalopram—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.000397	CcSEcCtD
Escitalopram—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	8.27e-05	0.000395	CcSEcCtD
Escitalopram—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000395	CcSEcCtD
Escitalopram—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	8.23e-05	0.000393	CcSEcCtD
Escitalopram—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	8.19e-05	0.000391	CcSEcCtD
Escitalopram—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	8.19e-05	0.000391	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	8.18e-05	0.000391	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	8.18e-05	0.000391	CcSEcCtD
Escitalopram—Insomnia—Formoterol—chronic obstructive pulmonary disease	8.12e-05	0.000388	CcSEcCtD
Escitalopram—Insomnia—Arformoterol—chronic obstructive pulmonary disease	8.12e-05	0.000388	CcSEcCtD
Escitalopram—Anorexia—Salbutamol—chronic obstructive pulmonary disease	8.08e-05	0.000386	CcSEcCtD
Escitalopram—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	8.07e-05	0.000386	CcSEcCtD
Escitalopram—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000384	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	8.01e-05	0.000383	CcSEcCtD
Escitalopram—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	8e-05	0.000382	CcSEcCtD
Escitalopram—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	8e-05	0.000382	CcSEcCtD
Escitalopram—Somnolence—Arformoterol—chronic obstructive pulmonary disease	7.98e-05	0.000381	CcSEcCtD
Escitalopram—Somnolence—Formoterol—chronic obstructive pulmonary disease	7.98e-05	0.000381	CcSEcCtD
Escitalopram—Insomnia—Montelukast—chronic obstructive pulmonary disease	7.95e-05	0.00038	CcSEcCtD
Escitalopram—Hypotension—Salbutamol—chronic obstructive pulmonary disease	7.92e-05	0.000378	CcSEcCtD
Escitalopram—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	7.9e-05	0.000377	CcSEcCtD
Escitalopram—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	7.9e-05	0.000377	CcSEcCtD
Escitalopram—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	7.89e-05	0.000377	CcSEcCtD
Escitalopram—Pruritus—Tiotropium—chronic obstructive pulmonary disease	7.87e-05	0.000376	CcSEcCtD
Escitalopram—Injury—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000374	CcSEcCtD
Escitalopram—Somnolence—Montelukast—chronic obstructive pulmonary disease	7.82e-05	0.000373	CcSEcCtD
Escitalopram—Dizziness—Aminophylline—chronic obstructive pulmonary disease	7.8e-05	0.000373	CcSEcCtD
Escitalopram—Weight increased—Prednisolone—chronic obstructive pulmonary disease	7.78e-05	0.000372	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	7.75e-05	0.00037	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	7.75e-05	0.00037	CcSEcCtD
Escitalopram—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	7.74e-05	0.00037	CcSEcCtD
Escitalopram—Fatigue—Formoterol—chronic obstructive pulmonary disease	7.74e-05	0.00037	CcSEcCtD
Escitalopram—Fatigue—Arformoterol—chronic obstructive pulmonary disease	7.74e-05	0.00037	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	7.72e-05	0.000369	CcSEcCtD
Escitalopram—Pain—Formoterol—chronic obstructive pulmonary disease	7.68e-05	0.000367	CcSEcCtD
Escitalopram—Pain—Arformoterol—chronic obstructive pulmonary disease	7.68e-05	0.000367	CcSEcCtD
Escitalopram—Constipation—Arformoterol—chronic obstructive pulmonary disease	7.68e-05	0.000367	CcSEcCtD
Escitalopram—Constipation—Formoterol—chronic obstructive pulmonary disease	7.68e-05	0.000367	CcSEcCtD
Escitalopram—Insomnia—Salbutamol—chronic obstructive pulmonary disease	7.67e-05	0.000366	CcSEcCtD
Escitalopram—Amnesia—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000365	CcSEcCtD
Escitalopram—Increased appetite—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.000365	CcSEcCtD
Escitalopram—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	7.61e-05	0.000364	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	7.59e-05	0.000363	CcSEcCtD
Escitalopram—Fatigue—Montelukast—chronic obstructive pulmonary disease	7.58e-05	0.000362	CcSEcCtD
Escitalopram—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	7.56e-05	0.000361	CcSEcCtD
Escitalopram—Somnolence—Salbutamol—chronic obstructive pulmonary disease	7.53e-05	0.00036	CcSEcCtD
Escitalopram—Pain—Montelukast—chronic obstructive pulmonary disease	7.52e-05	0.000359	CcSEcCtD
Escitalopram—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.000359	CcSEcCtD
Escitalopram—Vomiting—Aminophylline—chronic obstructive pulmonary disease	7.5e-05	0.000358	CcSEcCtD
Escitalopram—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	7.47e-05	0.000357	CcSEcCtD
Escitalopram—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	7.47e-05	0.000357	CcSEcCtD
Escitalopram—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	7.46e-05	0.000356	CcSEcCtD
Escitalopram—Purpura—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000356	CcSEcCtD
Escitalopram—Rash—Aminophylline—chronic obstructive pulmonary disease	7.44e-05	0.000355	CcSEcCtD
Escitalopram—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	7.43e-05	0.000355	CcSEcCtD
Escitalopram—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	7.41e-05	0.000354	CcSEcCtD
Escitalopram—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	7.4e-05	0.000353	CcSEcCtD
Escitalopram—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	7.4e-05	0.000353	CcSEcCtD
Escitalopram—Headache—Aminophylline—chronic obstructive pulmonary disease	7.39e-05	0.000353	CcSEcCtD
Escitalopram—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	7.37e-05	0.000352	CcSEcCtD
Escitalopram—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000352	CcSEcCtD
Escitalopram—Dizziness—Tiotropium—chronic obstructive pulmonary disease	7.35e-05	0.000351	CcSEcCtD
Escitalopram—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	7.34e-05	0.000351	CcSEcCtD
Escitalopram—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	7.34e-05	0.000351	CcSEcCtD
Escitalopram—Lethargy—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.00035	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	7.32e-05	0.00035	CcSEcCtD
Escitalopram—Fatigue—Salbutamol—chronic obstructive pulmonary disease	7.31e-05	0.000349	CcSEcCtD
Escitalopram—Constipation—Salbutamol—chronic obstructive pulmonary disease	7.25e-05	0.000346	CcSEcCtD
Escitalopram—Pain—Salbutamol—chronic obstructive pulmonary disease	7.25e-05	0.000346	CcSEcCtD
Escitalopram—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	7.19e-05	0.000343	CcSEcCtD
Escitalopram—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000343	CcSEcCtD
Escitalopram—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000343	CcSEcCtD
Escitalopram—Urticaria—Arformoterol—chronic obstructive pulmonary disease	7.13e-05	0.000341	CcSEcCtD
Escitalopram—Urticaria—Formoterol—chronic obstructive pulmonary disease	7.13e-05	0.000341	CcSEcCtD
Escitalopram—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	7.1e-05	0.000339	CcSEcCtD
Escitalopram—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	7.1e-05	0.000339	CcSEcCtD
Escitalopram—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	7.1e-05	0.000339	CcSEcCtD
Escitalopram—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	7.1e-05	0.000339	CcSEcCtD
Escitalopram—Affect lability—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000338	CcSEcCtD
Escitalopram—Vomiting—Tiotropium—chronic obstructive pulmonary disease	7.07e-05	0.000338	CcSEcCtD
Escitalopram—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000335	CcSEcCtD
Escitalopram—Rash—Tiotropium—chronic obstructive pulmonary disease	7.01e-05	0.000335	CcSEcCtD
Escitalopram—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	7.01e-05	0.000335	CcSEcCtD
Escitalopram—Nausea—Aminophylline—chronic obstructive pulmonary disease	7.01e-05	0.000335	CcSEcCtD
Escitalopram—Urticaria—Montelukast—chronic obstructive pulmonary disease	6.98e-05	0.000334	CcSEcCtD
Escitalopram—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	6.98e-05	0.000334	CcSEcCtD
Escitalopram—Headache—Tiotropium—chronic obstructive pulmonary disease	6.97e-05	0.000333	CcSEcCtD
Escitalopram—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000333	CcSEcCtD
Escitalopram—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.95e-05	0.000332	CcSEcCtD
Escitalopram—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.95e-05	0.000332	CcSEcCtD
Escitalopram—Face oedema—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000331	CcSEcCtD
Escitalopram—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.93e-05	0.000331	CcSEcCtD
Escitalopram—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	6.88e-05	0.000329	CcSEcCtD
Escitalopram—Irritability—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.000328	CcSEcCtD
Escitalopram—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000327	CcSEcCtD
Escitalopram—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	6.83e-05	0.000326	CcSEcCtD
Escitalopram—Mood swings—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000325	CcSEcCtD
Escitalopram—Urticaria—Salbutamol—chronic obstructive pulmonary disease	6.73e-05	0.000322	CcSEcCtD
Escitalopram—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	6.7e-05	0.00032	CcSEcCtD
Escitalopram—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	6.7e-05	0.00032	CcSEcCtD
Escitalopram—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	6.61e-05	0.000316	CcSEcCtD
Escitalopram—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	6.61e-05	0.000316	CcSEcCtD
Escitalopram—Nausea—Tiotropium—chronic obstructive pulmonary disease	6.61e-05	0.000316	CcSEcCtD
Escitalopram—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	6.59e-05	0.000315	CcSEcCtD
Escitalopram—Dry skin—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000315	CcSEcCtD
Escitalopram—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	6.54e-05	0.000312	CcSEcCtD
Escitalopram—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	6.48e-05	0.000309	CcSEcCtD
Escitalopram—Asthenia—Formoterol—chronic obstructive pulmonary disease	6.44e-05	0.000308	CcSEcCtD
Escitalopram—Asthenia—Arformoterol—chronic obstructive pulmonary disease	6.44e-05	0.000308	CcSEcCtD
Escitalopram—Pruritus—Arformoterol—chronic obstructive pulmonary disease	6.35e-05	0.000303	CcSEcCtD
Escitalopram—Pruritus—Formoterol—chronic obstructive pulmonary disease	6.35e-05	0.000303	CcSEcCtD
Escitalopram—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000303	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000303	CcSEcCtD
Escitalopram—Asthenia—Montelukast—chronic obstructive pulmonary disease	6.31e-05	0.000301	CcSEcCtD
Escitalopram—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000299	CcSEcCtD
Escitalopram—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	6.24e-05	0.000298	CcSEcCtD
Escitalopram—Pruritus—Montelukast—chronic obstructive pulmonary disease	6.22e-05	0.000297	CcSEcCtD
Escitalopram—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	6.14e-05	0.000293	CcSEcCtD
Escitalopram—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	6.14e-05	0.000293	CcSEcCtD
Escitalopram—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000292	CcSEcCtD
Escitalopram—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000291	CcSEcCtD
Escitalopram—Asthenia—Salbutamol—chronic obstructive pulmonary disease	6.08e-05	0.000291	CcSEcCtD
Escitalopram—Sweating increased—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000289	CcSEcCtD
Escitalopram—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	6.02e-05	0.000287	CcSEcCtD
Escitalopram—Pruritus—Salbutamol—chronic obstructive pulmonary disease	6e-05	0.000286	CcSEcCtD
Escitalopram—Erythema—Prednisolone—chronic obstructive pulmonary disease	5.96e-05	0.000285	CcSEcCtD
Escitalopram—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.94e-05	0.000284	CcSEcCtD
Escitalopram—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.94e-05	0.000284	CcSEcCtD
Escitalopram—Dizziness—Montelukast—chronic obstructive pulmonary disease	5.81e-05	0.000278	CcSEcCtD
Escitalopram—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.8e-05	0.000277	CcSEcCtD
Escitalopram—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000273	CcSEcCtD
Escitalopram—Vomiting—Formoterol—chronic obstructive pulmonary disease	5.71e-05	0.000273	CcSEcCtD
Escitalopram—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5.71e-05	0.000273	CcSEcCtD
Escitalopram—Rash—Arformoterol—chronic obstructive pulmonary disease	5.66e-05	0.00027	CcSEcCtD
Escitalopram—Rash—Formoterol—chronic obstructive pulmonary disease	5.66e-05	0.00027	CcSEcCtD
Escitalopram—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	5.65e-05	0.00027	CcSEcCtD
Escitalopram—Dermatitis—Formoterol—chronic obstructive pulmonary disease	5.65e-05	0.00027	CcSEcCtD
Escitalopram—Weight increased—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.00027	CcSEcCtD
Escitalopram—Headache—Arformoterol—chronic obstructive pulmonary disease	5.62e-05	0.000269	CcSEcCtD
Escitalopram—Headache—Formoterol—chronic obstructive pulmonary disease	5.62e-05	0.000269	CcSEcCtD
Escitalopram—Weight decreased—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000268	CcSEcCtD
Escitalopram—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	5.61e-05	0.000268	CcSEcCtD
Escitalopram—Dizziness—Salbutamol—chronic obstructive pulmonary disease	5.6e-05	0.000268	CcSEcCtD
Escitalopram—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000268	CcSEcCtD
Escitalopram—Vomiting—Montelukast—chronic obstructive pulmonary disease	5.59e-05	0.000267	CcSEcCtD
Escitalopram—Rash—Montelukast—chronic obstructive pulmonary disease	5.54e-05	0.000265	CcSEcCtD
Escitalopram—Dermatitis—Montelukast—chronic obstructive pulmonary disease	5.54e-05	0.000265	CcSEcCtD
Escitalopram—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000264	CcSEcCtD
Escitalopram—Depression—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000264	CcSEcCtD
Escitalopram—Headache—Montelukast—chronic obstructive pulmonary disease	5.51e-05	0.000263	CcSEcCtD
Escitalopram—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000261	CcSEcCtD
Escitalopram—Angioedema—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.00026	CcSEcCtD
Escitalopram—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000259	CcSEcCtD
Escitalopram—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000259	CcSEcCtD
Escitalopram—Vomiting—Salbutamol—chronic obstructive pulmonary disease	5.39e-05	0.000257	CcSEcCtD
Escitalopram—Malaise—Prednisolone—chronic obstructive pulmonary disease	5.37e-05	0.000257	CcSEcCtD
Escitalopram—Vertigo—Prednisolone—chronic obstructive pulmonary disease	5.35e-05	0.000256	CcSEcCtD
Escitalopram—Rash—Salbutamol—chronic obstructive pulmonary disease	5.34e-05	0.000255	CcSEcCtD
Escitalopram—Syncope—Prednisolone—chronic obstructive pulmonary disease	5.34e-05	0.000255	CcSEcCtD
Escitalopram—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	5.34e-05	0.000255	CcSEcCtD
Escitalopram—Nausea—Formoterol—chronic obstructive pulmonary disease	5.33e-05	0.000255	CcSEcCtD
Escitalopram—Nausea—Arformoterol—chronic obstructive pulmonary disease	5.33e-05	0.000255	CcSEcCtD
Escitalopram—Headache—Salbutamol—chronic obstructive pulmonary disease	5.31e-05	0.000254	CcSEcCtD
Escitalopram—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	5.23e-05	0.00025	CcSEcCtD
Escitalopram—Nausea—Montelukast—chronic obstructive pulmonary disease	5.22e-05	0.000249	CcSEcCtD
Escitalopram—Convulsion—Prednisolone—chronic obstructive pulmonary disease	5.16e-05	0.000247	CcSEcCtD
Escitalopram—Hypertension—Prednisolone—chronic obstructive pulmonary disease	5.14e-05	0.000246	CcSEcCtD
Escitalopram—Bradycardia—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000242	CcSEcCtD
Escitalopram—Nausea—Salbutamol—chronic obstructive pulmonary disease	5.03e-05	0.000241	CcSEcCtD
Escitalopram—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.01e-05	0.000239	CcSEcCtD
Escitalopram—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000239	CcSEcCtD
Escitalopram—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000238	CcSEcCtD
Escitalopram—Hallucination—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000236	CcSEcCtD
Escitalopram—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000233	CcSEcCtD
Escitalopram—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000232	CcSEcCtD
Escitalopram—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000232	CcSEcCtD
Escitalopram—Shock—Prednisolone—chronic obstructive pulmonary disease	4.78e-05	0.000228	CcSEcCtD
Escitalopram—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	4.74e-05	0.000227	CcSEcCtD
Escitalopram—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	4.7e-05	0.000225	CcSEcCtD
Escitalopram—Eye disorder—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000222	CcSEcCtD
Escitalopram—Flushing—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.00022	CcSEcCtD
Escitalopram—Angiopathy—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.000216	CcSEcCtD
Escitalopram—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000215	CcSEcCtD
Escitalopram—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000212	CcSEcCtD
Escitalopram—Insomnia—Prednisolone—chronic obstructive pulmonary disease	4.4e-05	0.00021	CcSEcCtD
Escitalopram—Alopecia—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.00021	CcSEcCtD
Escitalopram—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.36e-05	0.000209	CcSEcCtD
Escitalopram—Mental disorder—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000208	CcSEcCtD
Escitalopram—Erythema—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000207	CcSEcCtD
Escitalopram—Malnutrition—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000207	CcSEcCtD
Escitalopram—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.17e-05	0.00118	CbGpPWpGaD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.16e-05	0.00117	CbGpPWpGaD
Escitalopram—Pain—Prednisolone—chronic obstructive pulmonary disease	4.16e-05	0.000199	CcSEcCtD
Escitalopram—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000195	CcSEcCtD
Escitalopram—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.06e-05	0.00114	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.05e-05	0.00114	CbGpPWpGaD
Escitalopram—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000192	CcSEcCtD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.01e-05	0.00113	CbGpPWpGaD
Escitalopram—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.01e-05	0.000191	CcSEcCtD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4e-05	0.00113	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4e-05	0.00113	CbGpPWpGaD
Escitalopram—Anaemia—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000191	CcSEcCtD
Escitalopram—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4e-05	0.00113	CbGpPWpGaD
Escitalopram—Agitation—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.00019	CcSEcCtD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.97e-05	0.00112	CbGpPWpGaD
Escitalopram—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000189	CcSEcCtD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.94e-05	0.00111	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.93e-05	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.92e-05	0.00111	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.92e-05	0.0011	CbGpPWpGaD
Escitalopram—Malaise—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000186	CcSEcCtD
Escitalopram—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000186	CcSEcCtD
Escitalopram—Syncope—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.000185	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.87e-05	0.00109	CbGpPWpGaD
Escitalopram—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.86e-05	0.000184	CcSEcCtD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.86e-05	0.00109	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.84e-05	0.00108	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.83e-05	0.00108	CbGpPWpGaD
Escitalopram—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000182	CcSEcCtD
Escitalopram—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.79e-05	0.00107	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.78e-05	0.00107	CbGpPWpGaD
Escitalopram—Convulsion—Prednisone—chronic obstructive pulmonary disease	3.75e-05	0.000179	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.74e-05	0.00105	CbGpPWpGaD
Escitalopram—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.74e-05	0.000179	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.73e-05	0.00105	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.00105	CbGpPWpGaD
Escitalopram—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.7e-05	0.00104	CbGpPWpGaD
Escitalopram—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.68e-05	0.000176	CcSEcCtD
Escitalopram—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.68e-05	0.000176	CcSEcCtD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.68e-05	0.00104	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.68e-05	0.00104	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.67e-05	0.00104	CbGpPWpGaD
Escitalopram—Anxiety—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000175	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	3.66e-05	0.000175	CcSEcCtD
Escitalopram—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000174	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.58e-05	0.000171	CcSEcCtD
Escitalopram—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	3.56e-05	0.001	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.000996	CbGpPWpGaD
Escitalopram—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000169	CcSEcCtD
Escitalopram—Oedema—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000169	CcSEcCtD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.52e-05	0.000992	CbGpPWpGaD
Escitalopram—Infection—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000168	CcSEcCtD
Escitalopram—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000982	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.48e-05	0.000981	CbGpPWpGaD
Escitalopram—Shock—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000166	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.47e-05	0.000977	CbGpPWpGaD
Escitalopram—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000165	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.46e-05	0.000973	CbGpPWpGaD
Escitalopram—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.45e-05	0.000165	CcSEcCtD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.44e-05	0.000969	CbGpPWpGaD
Escitalopram—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.000164	CcSEcCtD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.43e-05	0.000966	CbGpPWpGaD
Escitalopram—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.41e-05	0.000163	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.4e-05	0.000958	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.39e-05	0.000955	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.38e-05	0.000951	CbGpPWpGaD
Escitalopram—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.37e-05	0.000161	CcSEcCtD
Escitalopram—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.35e-05	0.000944	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.34e-05	0.000941	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.34e-05	0.00094	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.29e-05	0.000926	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.22e-05	0.000154	CcSEcCtD
Escitalopram—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.21e-05	0.000154	CcSEcCtD
Escitalopram—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.000153	CcSEcCtD
Escitalopram—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.000896	CbGpPWpGaD
Escitalopram—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000152	CcSEcCtD
Escitalopram—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.16e-05	0.000891	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.14e-05	0.000884	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.12e-05	0.000879	CbGpPWpGaD
Escitalopram—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.11e-05	0.000149	CcSEcCtD
Escitalopram—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.09e-05	0.000872	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.09e-05	0.000871	CbGpPWpGaD
Escitalopram—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000147	CcSEcCtD
Escitalopram—Rash—Prednisolone—chronic obstructive pulmonary disease	3.06e-05	0.000146	CcSEcCtD
Escitalopram—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.06e-05	0.000146	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.06e-05	0.000862	CbGpPWpGaD
Escitalopram—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.05e-05	0.000145	CcSEcCtD
Escitalopram—Headache—Prednisolone—chronic obstructive pulmonary disease	3.05e-05	0.000145	CcSEcCtD
Escitalopram—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.02e-05	0.000852	CbGpPWpGaD
Escitalopram—Constipation—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000144	CcSEcCtD
Escitalopram—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.02e-05	0.00085	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.01e-05	0.000848	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.99e-05	0.000844	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.98e-05	0.000841	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.96e-05	0.000834	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.94e-05	0.000828	CbGpPWpGaD
Escitalopram—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.000139	CcSEcCtD
Escitalopram—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.000138	CcSEcCtD
Escitalopram—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.89e-05	0.000138	CcSEcCtD
Escitalopram—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.84e-05	0.000801	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.83e-05	0.000798	CbGpPWpGaD
Escitalopram—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.81e-05	0.000134	CcSEcCtD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.8e-05	0.00079	CbGpPWpGaD
Escitalopram—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.000133	CcSEcCtD
Escitalopram—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.000133	CcSEcCtD
Escitalopram—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.74e-05	0.000772	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.73e-05	0.00077	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.69e-05	0.000758	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000747	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.65e-05	0.000747	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000744	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.62e-05	0.000738	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.62e-05	0.000737	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.61e-05	0.000736	CbGpPWpGaD
Escitalopram—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.6e-05	0.000124	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.6e-05	0.000733	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.000724	CbGpPWpGaD
Escitalopram—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.53e-05	0.000121	CcSEcCtD
Escitalopram—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000119	CcSEcCtD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.45e-05	0.000691	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000687	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.42e-05	0.000682	CbGpPWpGaD
Escitalopram—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.42e-05	0.000115	CcSEcCtD
Escitalopram—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000677	CbGpPWpGaD
Escitalopram—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.34e-05	0.000112	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.32e-05	0.000653	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000651	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.000642	CbGpPWpGaD
Escitalopram—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.25e-05	0.000107	CcSEcCtD
Escitalopram—Rash—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000106	CcSEcCtD
Escitalopram—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000106	CcSEcCtD
Escitalopram—Headache—Prednisone—chronic obstructive pulmonary disease	2.21e-05	0.000106	CcSEcCtD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.2e-05	0.000621	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.19e-05	0.000616	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.000599	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.000597	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.11e-05	0.000595	CbGpPWpGaD
Escitalopram—Nausea—Prednisone—chronic obstructive pulmonary disease	2.1e-05	0.0001	CcSEcCtD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.1e-05	0.000591	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.000589	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.09e-05	0.000587	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.06e-05	0.00058	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.000577	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.03e-05	0.000572	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.01e-05	0.000566	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2e-05	0.000564	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.99e-05	0.000561	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.98e-05	0.000559	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.97e-05	0.000555	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.95e-05	0.00055	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.89e-05	0.000533	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.89e-05	0.000532	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000531	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.87e-05	0.000528	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.87e-05	0.000526	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.87e-05	0.000526	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000524	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.86e-05	0.000524	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.86e-05	0.000523	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.85e-05	0.000522	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.85e-05	0.000522	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000516	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.77e-05	0.0005	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.72e-05	0.000484	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.71e-05	0.000483	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.71e-05	0.000481	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.00048	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.7e-05	0.000478	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.000477	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.69e-05	0.000475	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.69e-05	0.000475	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.66e-05	0.000468	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.62e-05	0.000456	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.62e-05	0.000456	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.61e-05	0.000455	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.61e-05	0.000454	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000454	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000453	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.59e-05	0.000448	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000447	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.58e-05	0.000446	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.000437	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.54e-05	0.000433	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.53e-05	0.000431	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.51e-05	0.000425	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.000417	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.000416	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000416	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.000409	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.37e-05	0.000385	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.34e-05	0.000379	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.34e-05	0.000377	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.32e-05	0.000372	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.27e-05	0.000358	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.000347	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000337	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.18e-05	0.000334	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.18e-05	0.000332	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.17e-05	0.00033	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.16e-05	0.000327	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.000314	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.1e-05	0.00031	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.1e-05	0.000309	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000307	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.08e-05	0.000304	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000303	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000297	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.05e-05	0.000295	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.02e-05	0.000286	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.000285	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1e-05	0.000283	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000282	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.97e-06	0.000281	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-06	0.000279	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.81e-06	0.000277	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.58e-06	0.00027	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.52e-06	0.000268	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.16e-06	0.000258	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.14e-06	0.000258	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.12e-06	0.000257	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.08e-06	0.000256	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.05e-06	0.000255	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.04e-06	0.000255	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.03e-06	0.000254	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.97e-06	0.000253	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.91e-06	0.000251	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.52e-06	0.00024	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.32e-06	0.000234	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.3e-06	0.000234	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.28e-06	0.000233	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.25e-06	0.000232	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.22e-06	0.000232	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.15e-06	0.00023	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.1e-06	0.000228	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.94e-06	0.000224	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.91e-06	0.000223	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.79e-06	0.00022	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.54e-06	0.000212	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.44e-06	0.00021	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.38e-06	0.000208	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.36e-06	0.000207	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.24e-06	0.000204	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7e-06	0.000197	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.94e-06	0.000195	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.93e-06	0.000195	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-06	0.000193	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.69e-06	0.000188	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.57e-06	0.000185	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.54e-06	0.000184	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.47e-06	0.000182	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.38e-06	0.00018	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.37e-06	0.00018	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.07e-06	0.000171	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.05e-06	0.00017	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-06	0.00017	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.96e-06	0.000168	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.9e-06	0.000166	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.79e-06	0.000163	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.77e-06	0.000163	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.68e-06	0.00016	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.66e-06	0.000159	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.53e-06	0.000156	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.51e-06	0.000155	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.44e-06	0.000153	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.43e-06	0.000153	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.38e-06	0.000152	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.12e-06	0.000144	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.91e-06	0.000138	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.89e-06	0.000138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.81e-06	0.000136	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.66e-06	0.000131	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.65e-06	0.000131	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.6e-06	0.00013	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.58e-06	0.000129	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.54e-06	0.000128	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.47e-06	0.000126	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.47e-06	0.000126	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.44e-06	0.000125	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.42e-06	0.000125	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.35e-06	0.000123	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.27e-06	0.00012	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.22e-06	0.000119	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.17e-06	0.000117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.14e-06	0.000117	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	0.000116	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.98e-06	0.000112	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.97e-06	0.000112	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.95e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	0.000111	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.91e-06	0.00011	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.66e-06	0.000103	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.65e-06	0.000103	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.59e-06	0.000101	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.59e-06	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.57e-06	0.000101	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.52e-06	9.91e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.47e-06	9.79e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.18e-06	8.96e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.01e-06	8.48e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3e-06	8.45e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.95e-06	8.32e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.76e-06	7.76e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.75e-06	7.74e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.7e-06	7.62e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.69e-06	7.57e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.57e-06	7.24e-05	CbGpPWpGaD
